TRAVERE THERAPEUTICS, INC. Payments to Acquire Intangible Assets
TRAVERE THERAPEUTICS, INC. (TVTX) reported Payments to Acquire Intangible Assets of $43.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireIntangibleAssets · last filed 2026-08-04
- TRAVERE THERAPEUTICS, INC. payments to acquire intangible assets for the quarter ending 2026-06-30 was $21.07M, a 74.34% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. payments to acquire intangible assets for the quarter ending 2026-03-31 was $22.18M, a 88.20% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. payments to acquire intangible assets for the quarter ending 2025-12-31 was $19.24M, a 99.51% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. payments to acquire intangible assets for the quarter ending 2025-09-30 was $15.05M, a 83.69% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. payments to acquire intangible assets for fiscal 2025 was $58.16M, a 60.60% increase from fiscal 2024.
- TRAVERE THERAPEUTICS, INC. payments to acquire intangible assets for fiscal 2024 was $36.21M, a 12.93% decline from fiscal 2023.
- TRAVERE THERAPEUTICS, INC. payments to acquire intangible assets for fiscal 2023 was $41.59M, a 46.62% increase from fiscal 2022.
- TRAVERE THERAPEUTICS, INC. payments to acquire intangible assets for fiscal 2022 was $28.37M, a 48.90% increase from fiscal 2021.
| Period end | Payments to Acquire Intangible Assets 3 month | Payments to Acquire Intangible Assets 3 month as first filed | Payments to Acquire Intangible Assets 6 month | Payments to Acquire Intangible Assets 6 month as first filed | Payments to Acquire Intangible Assets 9 month | Payments to Acquire Intangible Assets 9 month as first filed | Payments to Acquire Intangible Assets 12 month | Payments to Acquire Intangible Assets 12 month as first filed | Payments to Acquire Intangible Assets 22 month | Payments to Acquire Intangible Assets 25 month | Payments to Acquire Intangible Assets 28 month | Payments to Acquire Intangible Assets 31 month | Payments to Acquire Intangible Assets 34 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $21.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $43.25M 10-Q · filed 2026-08-04 | $62.49M derived: sum of 3 quarters · filed 2026-08-04 | $77.54M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2026-03-31 | $22.18M 10-Q · filed 2026-05-04 | $41.42M derived: sum of 2 quarters · filed 2026-05-04 | $56.47M derived: sum of 3 quarters · filed 2026-05-04 | $68.55M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2025-12-31 | $19.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $34.29M derived: sum of 2 quarters · filed 2026-02-19 | $46.37M derived: sum of 3 quarters · filed 2026-08-04 | $58.16M 10-K · filed 2026-02-19 | |||||||||
| 2025-09-30 | $15.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $27.13M derived: sum of 2 quarters · filed 2026-08-04 | $38.92M 10-Q · filed 2025-10-30 | $48.56M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2025-06-30 | $12.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $23.87M 10-Q · filed 2026-08-04 | $33.51M derived: sum of 3 quarters · filed 2026-08-04 | $41.70M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2025-03-31 | $11.78M 10-Q · filed 2026-05-04 | $21.43M derived: sum of 2 quarters · filed 2026-05-04 | $29.62M derived: sum of 3 quarters · filed 2026-05-04 | $41.53M derived: sum of 4 quarters · filed 2026-05-04 | |||||||||
| 2024-12-31 | $9.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $17.84M derived: sum of 2 quarters · filed 2026-02-19 | $29.75M derived: sum of 3 quarters · filed 2026-02-19 | $36.21M 10-K · filed 2026-02-19 | |||||||||
| 2024-09-30 | $8.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $20.10M derived: sum of 2 quarters · filed 2025-10-30 | $26.57M 10-Q · filed 2025-10-30 | $32.07M derived: sum of 4 quarters · filed 2026-02-19 | |||||||||
| 2024-06-30 | $11.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $18.38M 10-Q · filed 2025-08-06 | $23.88M derived: sum of 3 quarters · filed 2026-02-19 | $28.80M derived: sum of 4 quarters · filed 2026-02-19 | |||||||||
| 2024-03-31 | $6.47M 10-Q · filed 2025-05-01 | $11.97M derived: sum of 2 quarters · filed 2026-02-19 | $16.89M derived: sum of 3 quarters · filed 2026-02-19 | $20.72M derived: sum of 4 quarters · filed 2026-02-19 | |||||||||
| 2023-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.42M derived: sum of 2 quarters · filed 2026-02-19 | $14.25M derived: sum of 3 quarters · filed 2026-02-19 | $41.59M 10-K · filed 2026-02-19 | |||||||||
| 2023-09-30 | $4.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $8.75M derived: sum of 2 quarters · filed 2024-10-31 | $36.09M 10-Q · filed 2024-10-31 | $40.25M derived: sum of 4 quarters · filed 2025-02-21 | |||||||||
| 2023-06-30 | $3.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $31.17M 10-Q · filed 2024-08-01 | $35.34M derived: sum of 3 quarters · filed 2025-02-21 | $42.96M derived: sum of 4 quarters · filed 2025-02-21 | |||||||||
| 2023-03-31 | $27.34M 10-Q · filed 2024-05-06 | $31.50M derived: sum of 2 quarters · filed 2025-02-21 | $39.12M derived: sum of 3 quarters · filed 2025-02-21 | $50.57M derived: sum of 4 quarters · filed 2025-02-21 | |||||||||
| 2022-12-31 | $4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $11.79M derived: sum of 2 quarters · filed 2025-02-21 | $23.23M derived: sum of 3 quarters · filed 2025-02-21 | $28.37M 10-K · filed 2025-02-21 | |||||||||
| 2022-09-30 | $7.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $19.06M derived: sum of 2 quarters · filed 2023-11-07 | $24.20M 10-Q · filed 2023-11-07 | $29.25M derived: sum of 4 quarters · filed 2024-02-20 | |||||||||
| 2022-06-30 | $11.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $16.58M 10-Q · filed 2023-08-03 | $21.63M derived: sum of 3 quarters · filed 2024-02-20 | $26.65M derived: sum of 4 quarters · filed 2024-02-20 | |||||||||
| 2022-03-31 | $5.14M 10-Q · filed 2023-05-04 | $10.18M derived: sum of 2 quarters · filed 2024-02-20 | $15.21M derived: sum of 3 quarters · filed 2024-02-20 | $19.41M derived: sum of 4 quarters · filed 2024-02-20 | |||||||||
| 2021-12-31 | $5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $10.07M derived: sum of 2 quarters · filed 2024-02-20 | $14.28M derived: sum of 3 quarters · filed 2024-02-20 | $19.05M 10-K · filed 2024-02-20 | |||||||||
| 2021-09-30 | $5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $9.23M derived: sum of 2 quarters · filed 2022-10-27 | $14.00M 10-Q · filed 2022-10-27 | $18.76M derived: sum of 4 quarters · filed 2023-02-23 | |||||||||
| 2021-06-30 | $4.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $8.98M 10-Q · filed 2022-08-04 | $13.74M derived: sum of 3 quarters · filed 2023-02-23 | $18.25M derived: sum of 4 quarters · filed 2023-02-23 | |||||||||
| 2021-03-31 | $4.78M 10-Q · filed 2022-05-05 | $9.54M derived: sum of 2 quarters · filed 2023-02-23 | $14.04M derived: sum of 3 quarters · filed 2023-02-23 | $18.17M derived: sum of 4 quarters · filed 2023-02-23 | |||||||||
| 2020-12-31 | $4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $9.27M derived: sum of 2 quarters · filed 2023-02-23 | $13.39M derived: sum of 3 quarters · filed 2023-02-23 | $17.80M 10-K · filed 2023-02-23 | |||||||||
| 2020-09-30 | $4.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $8.63M derived: sum of 2 quarters · filed 2021-10-29 | $13.04M 10-Q · filed 2021-10-29 | $17.11M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||
| 2020-06-30 | $4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $8.53M 10-Q · filed 2021-07-29 | $12.60M derived: sum of 3 quarters · filed 2022-02-24 | $16.55M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||
| 2020-03-31 | $4.41M 10-Q · filed 2021-05-06 | $8.48M derived: sum of 2 quarters · filed 2022-02-24 | $12.43M derived: sum of 3 quarters · filed 2022-02-24 | $15.81M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||
| 2019-12-31 | $4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $8.02M derived: sum of 2 quarters · filed 2022-02-24 | $11.41M derived: sum of 3 quarters · filed 2022-02-24 | $15.37M 10-K · filed 2022-02-24 | |||||||||
| 2019-09-30 | $3.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $7.34M derived: sum of 2 quarters · filed 2020-11-05 | $11.30M 10-Q · filed 2020-11-05 | $15.16M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||
| 2019-06-30 | $3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $7.35M 10-Q · filed 2020-07-31 | $11.21M derived: sum of 3 quarters · filed 2021-03-01 | $14.93M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||
| 2019-03-31 | $3.96M 10-Q · filed 2020-05-11 | $7.83M derived: sum of 2 quarters · filed 2021-03-01 | $11.55M derived: sum of 3 quarters · filed 2021-03-01 | $14.72M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||
| 2018-12-31 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $7.58M derived: sum of 2 quarters · filed 2021-03-01 | $10.76M derived: sum of 3 quarters · filed 2021-03-01 | $18.97M 10-K · filed 2021-03-01 | |||||||||
| 2018-09-30 | $3.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $6.89M derived: sum of 2 quarters · filed 2019-10-30 | $15.11M 10-Q · filed 2019-10-30 | $18.60M derived: sum of 4 quarters · filed 2020-02-24 | |||||||||
| 2018-06-30 | $3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $11.39M 10-Q · filed 2019-08-06 | $14.88M derived: sum of 3 quarters · filed 2020-02-24 | $18.23M derived: sum of 4 quarters · filed 2020-02-24 | |||||||||
| 2018-03-31 | $8.22M 10-Q · filed 2019-05-07 | $11.71M derived: sum of 2 quarters · filed 2020-02-24 | $15.06M derived: sum of 3 quarters · filed 2020-02-24 | $17.86M derived: sum of 4 quarters · filed 2020-02-24 | |||||||||
| 2017-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $6.84M derived: sum of 2 quarters · filed 2020-02-24 | $9.64M derived: sum of 3 quarters · filed 2020-02-24 | $13.12M 10-K · filed 2020-02-24 | |||||||||
| 2017-09-30 | $3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $6.16M derived: sum of 2 quarters · filed 2018-11-01 | $9.63M 10-Q · filed 2018-11-01 | $12.50M derived: sum of 4 quarters · filed 2019-02-26 | |||||||||
| 2017-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $6.28M 10-Q · filed 2018-08-03 | $9.14M derived: sum of 3 quarters · filed 2019-02-26 | $11.89M derived: sum of 4 quarters · filed 2019-02-26 | |||||||||
| 2017-03-31 | $3.48M 10-Q · filed 2018-07-06 | $6.34M derived: sum of 2 quarters · filed 2019-02-26 | $9.09M derived: sum of 3 quarters · filed 2019-02-26 | $11.40M derived: sum of 4 quarters · filed 2019-02-26 | |||||||||
| 2016-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $5.62M derived: sum of 2 quarters · filed 2019-02-26 | $7.92M derived: sum of 3 quarters · filed 2019-02-26 | $10.50M 10-K · filed 2019-02-26 | |||||||||
| 2016-09-30 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $5.06M derived: sum of 2 quarters · filed 2017-11-07 | $7.63M 10-Q · filed 2017-11-07 | $9.37M derived: sum of 4 quarters · filed 2018-07-06 | |||||||||
| 2016-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $4.88M 10-Q · filed 2017-08-09 | $6.62M derived: sum of 3 quarters · filed 2018-07-06 | $9.39M derived: sum of 4 quarters · filed 2018-07-06 | |||||||||
| 2016-03-31 | $2.58M 10-Q · filed 2017-05-05 | $4.31M derived: sum of 2 quarters · filed 2018-07-06 | $7.09M derived: sum of 3 quarters · filed 2018-07-06 | $8.63M derived: sum of 4 quarters · filed 2018-07-06 | |||||||||
| 2015-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | $4.51M derived: sum of 2 quarters · filed 2018-07-06 | $6.06M derived: sum of 3 quarters · filed 2018-07-06 | $7.01M 10-K · filed 2018-07-06 | |||||||||
| 2015-09-30 | $2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $4.32M derived: sum of 2 quarters · filed 2016-11-04 | $5.27M 10-Q · filed 2016-11-04 | $5.27M derived: sum of 4 quarters · filed 2017-03-01 | |||||||||
| 2015-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $2.50M 10-Q · filed 2016-08-05 | $1.40M 10-Q · filed 2015-08-10 | $2.50M derived: sum of 3 quarters · filed 2017-03-01 | $2.50M derived: sum of 4 quarters · filed 2017-03-01 | ||||||||
| 2015-03-31 | $948.00K 10-Q · filed 2016-05-05 | $947.00K derived: sum of 2 quarters · filed 2017-03-01 | $948.00K derived: sum of 3 quarters · filed 2017-03-01 | $4.19M derived: sum of 4 quarters · filed 2017-03-01 | |||||||||
| 2014-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $3.24M derived: sum of 3 quarters · filed 2017-03-01 | $3.30M 10-K · filed 2017-03-01 | $3.30M 10-K · filed 2015-03-11 | ||||||||
| 2014-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $3.24M derived: sum of 2 quarters · filed 2015-11-06 | $3.30M 10-Q · filed 2015-11-06 | $3.30M 10-Q · filed 2014-11-13 | $8.73M derived: sum of 4 quarters · filed 2016-02-26 | ||||||||
| 2014-06-30 | $3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $3.30M 10-Q · filed 2015-08-10 | $3.30M 10-Q · filed 2014-08-14 | $8.73M derived: sum of 3 quarters · filed 2016-02-26 | $8.73M derived: sum of 4 quarters · filed 2016-02-26 | ||||||||
| 2014-03-31 | $61.34K 10-Q · filed 2015-05-11 | $7.38K 10-Q · filed 2014-05-15 | $5.49M derived: sum of 2 quarters · filed 2016-02-26 | $5.49M derived: sum of 3 quarters · filed 2016-02-26 | $5.49M derived: sum of 4 quarters · filed 2016-02-26 | ||||||||
| 2013-12-31 | $5.43M derived: 10-K 12 month − 10-Q/A 9 month · filed 2016-02-26 | $5.43M derived: sum of 2 quarters · filed 2016-02-26 | $5.43M derived: sum of 3 quarters · filed 2016-02-26 | $5.43M 10-K · filed 2016-02-26 | $5.40M 10-K · filed 2014-03-28 | $5.40M 10-K/A · filed 2015-07-09 | |||||||
| 2013-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2015-07-09 | $5.70K derived: sum of 2 quarters · filed 2015-07-09 | $5.70K 10-Q/A · filed 2015-07-09 | -$2.32M derived: sum of 4 quarters · filed 2015-07-09 | $1.17M 10-Q/A · filed 2015-07-09 | ||||||||
| 2013-06-30 | $5.70K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-14 | $5.70K 10-Q · filed 2014-08-14 | -$2.32M derived: sum of 3 quarters · filed 2014-08-14 | -$2.25M derived: sum of 4 quarters · filed 2015-07-09 | $1.17M 10-Q · filed 2013-09-16 | ||||||||
| 2013-03-31 | $0.00 10-Q/A · filed 2013-09-16 | -$2.33M derived: sum of 2 quarters · filed 2013-09-16 | -$2.25M derived: sum of 3 quarters · filed 2015-07-09 | -$1.17M derived: sum of 4 quarters · filed 2015-07-09 | $1.17M 10-Q/A · filed 2013-09-16 | ||||||||
| 2012-12-31 | -$2.33M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2013-09-16 | -$2.25M derived: sum of 2 quarters · filed 2015-07-09 | -$1.17M derived: sum of 3 quarters · filed 2015-07-09 | -$1.17M 10-K/A · filed 2013-09-16 | -$1.17M 10-K/A · filed 2013-09-16 | ||||||||
| 2012-09-30 | $75.45K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2015-07-09 | $1.16M derived: sum of 2 quarters · filed 2015-07-09 | $1.16M 10-Q/A · filed 2015-07-09 | ||||||||||
| 2012-06-30 | $1.08M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-09-16 | $1.08M 10-Q · filed 2013-09-16 | |||||||||||
| 2012-03-31 | $0.00 10-Q/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |